Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-102 in Cancer Cachexia (ACT-ONE)
NCT01238107Phase 2Completed
- Sponsor
- Akamis Bio
- Start
- Apr 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of s-pindolol benzoate in cancer cachexia, sponsored by Akamis Bio. Started Apr 2011; status: completed.
02
Drugs
s-pindolol benzoate
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT01238107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01238107.